Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Tuberculosis

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 49 articles: HTML format Text format

Single Articles

March 2019
1. SAUNDERS MJ, Evans CA
   Ending Tuberculosis through Prevention.
   N Engl J Med. 2019;380:1073-1074.
   PubMed     Text format    
   
   
   
2. SWINDELLS S, Ramchandani R, Gupta A, Benson CA, et al
   One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis.
   N Engl J Med. 2019;380:1001-1011.
   PubMed     Text format     Abstract available
   
   
   
3. NUNN AJ, Phillips PPJ, Meredith SK, Chiang CY, et al
   A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis.
   N Engl J Med. 2019 Mar 13. doi: 10.1056/NEJMoa1811867.
   PubMed     Text format     Abstract available
   
   
   
4. CHURCHYARD GJ
   A Short Regimen for Rifampin-Resistant Tuberculosis.
   N Engl J Med. 2019 Mar 13. doi: 10.1056/NEJMe1902904.
   PubMed     Text format    
   
   
   January 2019
5. CHEN ST, Cahalane AM, Ryan ET, Foreman RK, et al
   Case 2-2019: A 36-Year-Old Man with Rash, Abdominal Pain, and Lymphadenopathy.
   N Engl J Med. 2019;380:275-283.
   PubMed     Text format    
   
   
   
6. ALSULTAN A, Ashkin D, Peloquin CA
   Bacterial Factors and Relapse after Tuberculosis Therapy.
   N Engl J Med. 2019;380:197.
   PubMed     Text format    
   
   
   
7. 
   Bacterial Factors and Relapse after Tuberculosis Therapy.
   N Engl J Med. 2019;380:197-198.
   PubMed     Text format    
   
   
   November 2018
8. 
   H4:IC31 Vaccine or BCG Revaccination for Tuberculosis.
   N Engl J Med. 2018;379:1969.
   PubMed     Text format    
   
   
   
9. MEINTJES G, Stek C, Blumenthal L, Thienemann F, et al
   Prednisone for the Prevention of Paradoxical Tuberculosis-Associated IRIS.
   N Engl J Med. 2018;379:1915-1925.
   PubMed     Text format     Abstract available
   
   
   September 2018
10. RUBIN AK, Burk KS, Staller K, Kunitake H, et al
    Case 30-2018: A 66-Year-Old Woman with Chronic Abdominal Pain.
    N Engl J Med. 2018;379:1263-1272.
    PubMed     Text format    
    
    
    
11. COX H, Mizrahi V
    The Coming of Age of Drug-Susceptibility Testing for Tuberculosis.
    N Engl J Med. 2018 Sep 26. doi: 10.1056/NEJMe1811861.
    PubMed     Text format    
    
    
    
12. 
    Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing.
    N Engl J Med. 2018 Sep 26. doi: 10.1056/NEJMoa1800474.
    PubMed     Text format     Abstract available
    
    
    
13. BLOOM BR
    New Promise for Vaccines against Tuberculosis.
    N Engl J Med. 2018 Sep 25. doi: 10.1056/NEJMe1812483.
    PubMed     Text format    
    
    
    
14. VAN DER MEEREN O, Hatherill M, Nduba V, Wilkinson RJ, et al
    Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis.
    N Engl J Med. 2018 Sep 25. doi: 10.1056/NEJMoa1803484.
    PubMed     Text format     Abstract available
    
    
    
15. MANDAL J, Margaretten M
    Tuberculosis of the Finger.
    N Engl J Med. 2018;379:1161.
    PubMed     Text format    
    
    
    
16. OKAMOTO K, Hatakeyama S
    Tuberculous Peritonitis.
    N Engl J Med. 2018;379:e20.
    PubMed     Text format    
    
    
    August 2018
17. COLANGELI R, Jedrey H, Kim S, Connell R, et al
    Bacterial Factors That Predict Relapse after Tuberculosis Therapy.
    N Engl J Med. 2018;379:823-833.
    PubMed     Text format     Abstract available
    
    
    
18. RUBIN EJ
    Of MICs and Men.
    N Engl J Med. 2018;379:882-883.
    PubMed     Text format    
    
    
    
19. MENZIES D, Adjobimey M, Ruslami R, Trajman A, et al
    Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults.
    N Engl J Med. 2018;379:440-453.
    PubMed     Text format     Abstract available
    
    
    
20. DIALLO T, Adjobimey M, Ruslami R, Trajman A, et al
    Safety and Side Effects of Rifampin versus Isoniazid in Children.
    N Engl J Med. 2018;379:454-463.
    PubMed     Text format     Abstract available
    
    
    July 2018
21. NEMES E, Geldenhuys H, Rozot V, Rutkowski KT, et al
    Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination.
    N Engl J Med. 2018;379:138-149.
    PubMed     Text format     Abstract available
    
    
    May 2018
22. YATES TA
    Household-Contact Investigation for Detection of Tuberculosis in Vietnam.
    N Engl J Med. 2018;378:2140-1.
    PubMed     Text format    
    
    
    
23. JAIN Y, Laux T, Patil S
    Household-Contact Investigation for Detection of Tuberculosis in Vietnam.
    N Engl J Med. 2018;378:2140.
    PubMed     Text format    
    
    
    
24. 
    Household-Contact Investigation for Detection of Tuberculosis in Vietnam.
    N Engl J Med. 2018;378:2140-2141.
    PubMed     Text format    
    
    
    
25. FARIA D, Freitas A
    Tuberculous Pericarditis.
    N Engl J Med. 2018;378:e27.
    PubMed     Text format    
    
    
    
26. MCBRIDE JA, Lepak AJ, Dhaliwal G, Saint S, et al
    The Wrong Frame of Mind.
    N Engl J Med. 2018;378:1716-1721.
    PubMed     Text format    
    
    
    March 2018
27. THOMPSON RW, Yu H, Dahl DM, Hurtado RM, et al
    Case 10-2018: An 84-Year-Old Man with Painless Unilateral Testicular Swelling.
    N Engl J Med. 2018;378:1233-1240.
    PubMed     Text format    
    
    
    February 2018
28. BAO Y, Zheng Y
    Drug-Resistant Miliary Tuberculosis in a Child.
    N Engl J Med. 2018;378:e10.
    PubMed     Text format    
    
    
    January 2018
29. FOX GJ, Nhung NV, Sy DN, Hoa NLP, et al
    Household-Contact Investigation for Detection of Tuberculosis in Vietnam.
    N Engl J Med. 2018;378:221-229.
    PubMed     Text format     Abstract available
    
    
    December 2017
30. GREENE JA, Loscalzo J
    Putting the Patient Back Together - Social Medicine, Network Medicine, and the Limits of Reductionism.
    N Engl J Med. 2017;377:2493-2499.
    PubMed     Text format    
    
    
    
31. MAITRE T, Aubry A, Veziris N
    Molecular Drug-Susceptibility Test for Tuberculosis.
    N Engl J Med. 2017;377:2403-4.
    PubMed     Text format    
    
    
    
32. 
    Molecular Drug-Susceptibility Test for Tuberculosis.
    N Engl J Med. 2017;377:2403-2404.
    PubMed     Text format    
    
    
    September 2017
33. BAYER R, Castro KG
    Tuberculosis Elimination in the United States - The Need for Renewed Action.
    N Engl J Med. 2017;377:1109-1111.
    PubMed     Text format    
    
    
    
34. XIE YL, Chakravorty S, Armstrong DT, Hall SL, et al
    Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis.
    N Engl J Med. 2017;377:1043-1054.
    PubMed     Text format     Abstract available
    
    
    August 2017
35. LETOURNEAU AR, Price MC, Azar MM
    Case 26-2017.
    N Engl J Med. 2017;377:770-778.
    PubMed     Text format    
    
    
    June 2017
36. DAVID WS, Bowley MP, Mehan WA Jr, Shin JH, et al
    Case 19-2017 - A 53-Year-Old Woman with Leg Numbness and Weakness.
    N Engl J Med. 2017;376:2471-2481.
    PubMed     Text format    
    
    
    
37. RUBIN EJ
    Reviving a Drug for Tuberculosis?
    N Engl J Med. 2017;376:2292-2294.
    PubMed     Text format    
    
    
    March 2017
38. KORATALA A, Bhatti V
    Incidental Finding of Oleothorax.
    N Engl J Med. 2017;376:e21.
    PubMed     Text format    
    
    
    February 2017
39. GISMONDI RA, de Souza LF
    Empyema Necessitatis.
    N Engl J Med. 2017;376:e13.
    PubMed     Text format    
    
    
    January 2017
40. CASADEVALL A
    Antibodies to Mycobacterium tuberculosis.
    N Engl J Med. 2017;376:283-285.
    PubMed     Text format    
    
    
    
41. SHAH NS, Auld SC, Brust JC, Mathema B, et al
    Transmission of Extensively Drug-Resistant Tuberculosis in South Africa.
    N Engl J Med. 2017;376:243-253.
    PubMed     Text format     Abstract available
    
    
    December 2016
42. BRUST JC, Shah NS, Gandhi NR
    More on Treatment Outcomes in Multidrug-Resistant Tuberculosis.
    N Engl J Med. 2016;375:2610.
    PubMed     Text format    
    
    
    
43. 
    More on Treatment Outcomes in Multidrug-Resistant Tuberculosis.
    N Engl J Med. 2016;375:2609-2611.
    PubMed     Text format    
    
    
    
44. DIACON AH, Van Baelen B, Theeuwes M
    More on Treatment Outcomes in Multidrug-Resistant Tuberculosis.
    N Engl J Med. 2016;375:2609-10.
    PubMed     Text format    
    
    
    
45. SALFINGER M, Somoskovi A
    More on Treatment Outcomes in Multidrug-Resistant Tuberculosis.
    N Engl J Med. 2016;375:2609.
    PubMed     Text format    
    
    
    September 2016
46. GUNTHER G, Lange C, Alexandru S, Altet N, et al
    Treatment Outcomes in Multidrug-Resistant Tuberculosis.
    N Engl J Med. 2016;375:1103-5.
    PubMed     Text format    
    
    
    
47. MASUDA H, Kamada K
    IMAGES IN CLINICAL MEDICINE. Urinary Tract Tuberculosis.
    N Engl J Med. 2016;375:1068.
    PubMed     Text format    
    
    
    
48. ZIGNOL M, Dean AS, Falzon D, van Gemert W, et al
    Twenty Years of Global Surveillance of Antituberculosis-Drug Resistance.
    N Engl J Med. 2016;375:1081-9.
    PubMed     Text format    
    
    
    
49. LEGRO RS, Hurtado RM, Kilcoyne A, Roberts DJ, et al
    CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 28-2016: A 31-Year-Old Woman with Infertility.
    N Engl J Med. 2016;375:1069-77.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: